Lilly (Eli) & Co. (LLY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

LILLY CORPORATE CTR INDIANAPOLIS, IN 46285

Eli Lilly and Company discovers, develops, manufactures, and sells products in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 17 other countries. Its products are sold in approximately 128 countries. The Company's products include Neuroscience products, Endocrinology products, Oncology products, Cardiovascular products, Animal health products, and other pharmaceuticals. In the United States, Eli Lilly and Company distributes pharmaceutical products principally through independent wholesale distributors, with some sales directly to pharmacies.

Data based on most recent fiscal year report
Market Cap85.379 Billion Shares Outstanding1.101 Billion Avg Volume6.143 Million
1-Yr BETA vs S&P TR Current Ratio1.32 Quick Ratio1.01
View SEC Filings from LLY instead.
Q2 2019 All Institutions Hedge Funds 1
To trade LLY now:
Filers who had this stock in their top 10: 25 6 (0.62%)
13F Filers holding this stock: 1447 109 (11.26%)
Aggregate 13F shares on 06/30/2019: 740.289 Million 28.876 Million
Aggregate 13F shares on 03/31/2019: 771.722 Million 26.66 Million
Percent change: -4.07% 8.31%
Funds creating new positions: 88 21
Funds Adding to an existing position: 453 33
Funds closing out their position: 147 11
Funds reducing their position: 640 33
Heat Map Ranking for 06/30/2019 128
Heat Map Ranking for 03/31/2019 38
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LLY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

13.4 Thousand total shares from 5 transactions

Open Market Sells (S)

593.9 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LILLY ENDOWMENT INC

  • 10% Owner
116,220,902 2019-11-12 20

ZULUETA ALFONSO G

  • Director
8,600 2019-11-07 7

PUSEY LEIGH ANN

  • Director
0 2019-11-01 1

ESKEW MICHAEL L

  • Director
42,025 2019-10-29 1

RICKS DAVID A PRESIDENT & CEO

  • Officer
  • Director
163,743 2019-10-25 3

LECHLEITER JOHN C

  • Director
90,000 2019-10-25 0

SMILEY JOSHUA L SVP AND CFO

  • Officer
33,553 2019-10-25 5

SKOVRONSKY DANIEL SVP, CSO, AND PRES. LRL

  • Officer
75,818 2019-10-25 2

WHITE ANNE E. SVP & PRES-LILLY ONCOLOGY

  • Officer
22,043 2019-10-25 3

TAI JACKSON P

  • Director
56,440 2019-10-24 12

ALVAREZ RALPH

  • Director
44,950 2019-10-21 12

LUCIANO JUAN R

  • Director
9,338 2019-10-21 12

WALKER KAREN

  • Director
1,170 2019-10-21 12

JACKSON JAMERE EVP CHIEF FINANCIAL OFFICER

  • Officer
92,915 2019-10-01 1

RICE DERICA W

  • Director
1,358 2019-09-30 0

TAUREL SIDNEY

0 2019-09-30 0

CONNELLY DEIRDRE P

0 2019-09-30 0

TAPIERO JACQUES

  • Director
9,678 2019-09-13 0

HANISH ARNOLD C

  • Director
0 2019-09-10 0

FRY STEPHEN F SVP, HR & DIVERSITY

  • Officer
100,211 2019-09-05 5

SIMMONS JEFFREY N PRESIDENT, CEO & DIRECTOR

  • Officer
  • Director
470,006 2019-09-04 1

FYRWALD J ERIK

6,800 2019-09-03 2

JONSSON PATRIK SVP AND PRES., LILLY BIO-MEDS

  • Officer
19,377 2019-09-01 1

HOOVER R DAVID

  • Director
50,499 2019-08-22 0

BAICKER KATHERINE

  • Director
3,182 2019-08-08 1

MAHONY SUSAN

  • Director
0 2019-08-01 0

PRENDERGAST FRANKLYN G

  • Director
0 2019-07-23 0

PAUL STEVEN M PRESIDENT & CEO

  • Officer
  • Director
106,485 2019-07-02 0

JOHNSON JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
37,400 2019-06-27 0

SANTINI GINO

  • Director
7,284 2019-06-20 0

LUNDBERG JAN M

  • Director
29,121 2019-06-13 0

HARRINGTON MICHAEL J SENIOR VP AND GENERAL COUNSEL

  • Officer
173,247 2019-06-03 5

SEIFERT KATHI P

  • Director
12,926 2019-05-21 1

SHAW CHRISTI

  • Director
14,286 2019-05-21 3

PETERSON BARTON R

  • Director
43,781 2019-05-14 0

HORN KAREN N

  • Director
14,303 2019-05-08 0

CROWE MARIA A

  • Director
14,569 2019-05-08 0

MARRAM ELLEN R

  • Director
56,645 2019-04-15 5

BARNES MELISSA S CHIEF ETH/CMPL OFCR & SVP, ERM

  • Officer
22,982 2019-04-12 4

SHAH AARTI S. SVP & CIO

  • Officer
20,134 2019-04-05 4

ZAKROWSKI DONALD A CHIEF ACCOUNTING OFFICER

  • Officer
6,262 2019-03-22 5

NORTON JOHNA SENIOR VP, GLOBAL QUALITY

  • Officer
23,917 2019-02-16 3

CONTERNO ENRIQUE A SVP&PRES, LILLYDIAB & LILLYUSA

  • Officer
138,121 2019-02-15 4

O'NEILL MYLES SVP & PRES., MFG. OPERATIONS

  • Officer
100,234 2019-02-01 4

OBERHELMAN DOUGLAS R

  • Director
18,000 2019-01-02 0

KAELIN WILLIAM G JR

  • Director
15,282 2018-11-19 1

RUNGE MARSCHALL S

  • Director
11,014 2018-11-19 1

BERTOZZI CAROLYN R

  • Director
3,307 2018-11-19 1

AZAR ALEX M II

  • Director
17,034 2017-09-30 0

BISCHOFF WINFRIED F W SIR

  • Director
No longer subject to file 2017-04-27 0

WALSH FIONNUALA M SVP, GLOBAL QUALITY

  • Officer
109,501 2017-02-01 0

COOK J MICHAEL

  • Director
27,076 2016-03-14 0

GILMAN ALFRED G

  • Director
8,912 2015-08-06 0

TALLARIGO LORENZO

  • Director
0 2014-07-07 0

DEANE FRANK M PRESIDENT, MFG. OPERATIONS

  • Officer
36,514 2012-02-01 0

CARMINE BRYCE D. EVP AND PRES, LILLY BIO-MEDS

  • Officer
109,516 2012-02-01 0

ARMITAGE ROBERT A SR. VP AND GENERAL COUNSEL

  • Officer
134,132 2012-02-01 0

NOBLES ANNE CHIEF ETH/CMPL OFCR & SVP, ERM

  • Officer
30,277 2012-01-26 0

FELDSTEIN MARTIN S

  • Director
30,733 2011-11-30 0

MURPHY ANTHONY JOHN SENIOR VP, HUMAN RESOURCES

  • Officer
54,892 2009-02-02 0

FISHER GEORGE M C

  • Director
4,752 2008-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LILLY ENDOWMENT INC - > 10% Owner

2019-11-12 S 7,981 $114.00 d 116,220,902 116,220,902.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-11-11 S 100 $114.07 d 116,228,883 116,228,883.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-11-07 S 400 $114.37 d 116,228,983 116,228,983.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-11-06 S 173,918 $114.05 d 116,229,383 116,229,383.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-11-04 S 7,003 $114.04 d 116,403,301 116,403,301.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-10-31 S 7,593 $114.55 d 116,410,304 116,410,304.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-10-31 S 182,407 $113.98 d 116,417,897 116,410,304.00 direct

SKOVRONSKY DANIEL - Officer SVP, CSO, AND PRES. LRL

2019-10-25 P 5,000 $108.61 a 75,818 75,818.00 direct

RICKS DAVID A - Director - Officer PRESIDENT & CEO

2019-10-25 P 4,615 $108.38 a 157,405 163,743.00 direct

SMILEY JOSHUA L - Officer SVP AND CFO

2019-10-25 P 929 $107.59 a 31,524 33,553.00 direct

WHITE ANNE E. - Officer SVP & PRES-LILLY ONCOLOGY

2019-10-25 P 1,000 $108.84 a 22,043 22,043.00 direct

TAI JACKSON P - Director

2019-10-24 P 1,861 $107.49 a 56,440 56,440.00 direct

LUCIANO JUAN R - Director

2019-10-21 A 126 $107.91 a 9,338 9,338.00 direct

WALKER KAREN - Director

2019-10-21 A 115 $107.91 a 1,170 1,170.00 direct

ALVAREZ RALPH - Director

2019-10-21 A 101 $107.91 a 44,950 44,950.00 direct

TAI JACKSON P - Director

2019-10-21 A 18 $107.91 a 54,579 54,579.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-09-20 S 96,800 $116.61 d 116,600,304 116,600,304.00 direct

LILLY ENDOWMENT INC - > 10% Owner

2019-09-20 S 113,200 $116.17 d 116,697,104 116,600,304.00 direct

ZULUETA ALFONSO G - Officer SVP & PRESIDENT, LILLY INT'L

2019-09-20 S 4,500 $117.00 d 33,806 38,370.00 direct yes

WALKER KAREN - Director

2019-09-16 A 113 $110.13 a 1,055 1,055.00 direct

LUCIANO JUAN R - Director

2019-09-16 A 123 $110.13 a 9,212 9,212.00 direct

ALVAREZ RALPH - Director

2019-09-16 A 99 $110.13 a 44,849 44,849.00 direct

TAI JACKSON P - Director

2019-09-16 A 18 $110.13 a 54,561 54,561.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments